Microsporidiosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Microsporidiosis}} | {{Microsporidiosis}} | ||
{{CMG}}; {{ | {{CMG}}; {{AE}} {{Ochuko}} {{AY}} | ||
==Overview== | ==Overview== | ||
The overall [[prevalence]] is not accurately estimated especially in the whole population (because | The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlating [[gastrointestinal tract]] symptoms to microsporidiosis). The disease is present all over the world. In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidiosis was 39% being the most common isolated organism. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence:=== | ===Prevalence:=== | ||
*The overall [[prevalence]] is not accurately estimated especially in the whole population (because | *The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlating [[gastrointestinal tract]] symptoms to microsporidiosis).<ref name="pmid7942725">{{cite journal |vauthors=Kotler DP, Orenstein JM |title=Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation |journal=Am. J. Gastroenterol. |volume=89 |issue=11 |pages=1998–2002 |year=1994 |pmid=7942725 |doi= |url=}}</ref><ref name="urlCDC - DPDx - Microsporidiosis">{{cite web |url=https://www.cdc.gov/dpdx/microsporidiosis/index.html |title=CDC - DPDx - Microsporidiosis |format= |work= |accessdate=}}</ref> | ||
*In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of | *In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidiosis was 39% being the most common isolated organism. | ||
=== Case fatality rate: === | === Case fatality rate: === | ||
| Line 15: | Line 15: | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to the | *There is no racial predilection to the microsporidiosis.<ref name="pmid16940873">{{cite journal| author=Didier ES, Weiss LM| title=Microsporidiosis: current status. | journal=Curr Opin Infect Dis | year= 2006 | volume= 19 | issue= 5 | pages= 485-92 | pmid=16940873 | doi=10.1097/01.qco.0000244055.46382.23 | pmc=3109650 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16940873 }} </ref> | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop | *Patients of all age groups may develop microsporidiosis.<ref name="pmid16940873">{{cite journal| author=Didier ES, Weiss LM| title=Microsporidiosis: current status. | journal=Curr Opin Infect Dis | year= 2006 | volume= 19 | issue= 5 | pages= 485-92 | pmid=16940873 | doi=10.1097/01.qco.0000244055.46382.23 | pmc=3109650 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16940873 }} </ref> | ||
===Sex=== | ===Sex=== | ||
*Males and females are affected equally by | *Males and females are affected equally by microsporidiosis.<ref name="pmid16940873">{{cite journal| author=Didier ES, Weiss LM| title=Microsporidiosis: current status. | journal=Curr Opin Infect Dis | year= 2006 | volume= 19 | issue= 5 | pages= 485-92 | pmid=16940873 | doi=10.1097/01.qco.0000244055.46382.23 | pmc=3109650 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16940873 }} </ref> | ||
===Geographic distribution=== | ===Geographic distribution=== | ||
*Microsporidiosis infections occur worldwide with no geographic predilection.<ref name="urlCDC - DPDx - Microsporidiosis">{{cite web |url=https://www.cdc.gov/dpdx/microsporidiosis/index.html |title=CDC - DPDx - Microsporidiosis |format= |work= |accessdate=}}</ref> | *Microsporidiosis infections occur worldwide with no geographic predilection.<ref name="urlCDC - DPDx - Microsporidiosis">{{cite web |url=https://www.cdc.gov/dpdx/microsporidiosis/index.html |title=CDC - DPDx - Microsporidiosis |format= |work= |accessdate=}}</ref> | ||
| Line 25: | Line 25: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Ophthalmology]] | |||
[[Category:Neurology]] | |||
[[Category:Dermatology]] | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
Latest revision as of 22:43, 29 July 2020
|
Microsporidiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Microsporidiosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Microsporidiosis epidemiology and demographics |
|
Risk calculators and risk factors for Microsporidiosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2] Ahmed Younes M.B.B.CH [3]
Overview
The overall prevalence is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in immunocompromised patients with correlating gastrointestinal tract symptoms to microsporidiosis). The disease is present all over the world. In HIV patients with diarrhea, the prevalence of microsporidiosis was 39% being the most common isolated organism.
Epidemiology and Demographics
Prevalence:
- The overall prevalence is not accurately estimated especially in the whole population (because microsporidiosis is usually investigated in immunocompromised patients with correlating gastrointestinal tract symptoms to microsporidiosis).[1][2]
- In HIV patients with diarrhea, the prevalence of microsporidiosis was 39% being the most common isolated organism.
Case fatality rate:
- The case-fatality rate of intestinal microsporidiosis is approximately 56% among HIV patients.
Race
- There is no racial predilection to the microsporidiosis.[3]
Age
- Patients of all age groups may develop microsporidiosis.[3]
Sex
- Males and females are affected equally by microsporidiosis.[3]
Geographic distribution
- Microsporidiosis infections occur worldwide with no geographic predilection.[2]
References
- ↑ Kotler DP, Orenstein JM (1994). "Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation". Am. J. Gastroenterol. 89 (11): 1998–2002. PMID 7942725.
- ↑ 2.0 2.1 "CDC - DPDx - Microsporidiosis".
- ↑ 3.0 3.1 3.2 Didier ES, Weiss LM (2006). "Microsporidiosis: current status". Curr Opin Infect Dis. 19 (5): 485–92. doi:10.1097/01.qco.0000244055.46382.23. PMC 3109650. PMID 16940873.